Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Mid-Term Results of a Single Intrastromal Corneal Ring Segment for Mild to Moderate Progressive Keratoconus Publisher Pubmed



Miraftab M1 ; Hashemi H2 ; Hafezi F3, 4, 5, 6 ; Asgari S7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran, Iran
  2. 2. Noor Research Center for Ophthalmic Epidemiology, Noor Eye Hospital, Tehran, Iran
  3. 3. Laboratory for Ocular Cell Biology Laboratory, University of Geneva, Geneva, Switzerland
  4. 4. Center for Applied Biotechnology and Molecular Medicine, University of Zurich, Zurich, Switzerland
  5. 5. Department of Ophthalmology, University of Southern California, Los Angeles, CA, United States
  6. 6. ELZA Institute, Dietikon, Switzerland
  7. 7. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, 1417613181, Iran

Source: Cornea Published:2017


Abstract

Purpose: To study the mid-term effects of implanting a single intracorneal ring segment (ICRS) for treatment of mild to moderate progressive keratoconus. Methods: This retrospective study was conducted on patients with progressive keratoconus treated with ICRS. The mean follow-up time was 15.2 6 8.8 (range, 7-26) months before and 27.8 ± 7.5 (range, 18-35) months after surgery. Patients received no other treatment during this time. Of the cases studied, 59.1% had inferior keratoconus. Results: Thirty eyes of 30 patients with a mean age of 27.5 ± 4.6 years were included in the study. Corrected distance visual acuity decreased by 1 line during the preoperative follow-up and improved by 2 lines after surgery (P < 0.05). Maximum keratometry (Kmax) of the anterior (2.39 ± 0.75 D) and posterior (0.33 ± 0.32 D) corneas at 3 mm and anterior Kmax at 8 mm (2.39 ± 0.95 D) decreased after treatment (all P < 0.05). The posterior Q value shifted toward a more oblate curvature (0.50 ± 0.52, P = 0.023). Decreases in anterior elevation at the thinnest point (5.22 ± 7.21 μm) and posterior corneal central elevation (8.89 ± 11.26 μm) were significant (both P < 0.05). Corneal thickness at the center (11.11 ± 12.38 μm) and thinnest point (15.89 ± 12.75 μm) increased after treatment (all P < 0.001). Other significant changes included postoperative decreases in the keratoconus index (0.12 ± 0.06), index of height decentration (0.06 ± 0.05), index of surface variance (27.32 ± 13.08), index of vertical asymmetry (0.42 ± 0.21), index of height asymmetry (8.42 ± 20.57), and an increase in the center keratoconus index (0.01 ± 0.02) (P < 0.001). Conclusions: This study demonstrates that ICRS implantation provides favorable mid-term outcomes in treatment of mild and moderate progressive keratoconus and can improve corneal indices compared with their preoperative states. © 2016 Wolters Kluwer Health, Inc. All rights reserved.
Other Related Docs
14. Updates on Managements for Keratoconus, Journal of Current Ophthalmology (2018)
16. Long-Term Results of Myoring Implantation in Patients With Keratoconus, Clinical and Experimental Optometry (2021)
27. Myoring Implantation in Keratoconic Patients: 3 Years Follow-Up Data, Journal of Ophthalmic and Vision Research (2016)
30. Corneal Cross-Linking: Epi-Off Versus Epi-On Versus Epi-Partially-Off Techniques, Keratoconus: Optical and Surgical Management (2024)